PapersPMID:34588374
A Randomized, Double-Blind Comparison Study of Royal Jelly to Augment Vascular Endothelial Function in Healthy Volunteers.
- findings
- 2
- compound
- 1
- endpoints
- 2
- no difference found
- 1
- Study, every finding
- RCT · 4 weeks
- Dose studied, every finding
- 690 mg dried royal jelly (equivalent to 2040 mg fresh royal jelly) as tablets daily for 4 weeks
- Population, every finding
- Healthy Japanese volunteers aged 20–60 without diabetes, hypertension or dyslipidaemia, non-smokers
What moved
How to read these marks →“The percentage relative changes in ALT and γGT were significantly lower in the royal jelly group than in the placebo group (ALT: −6.06%±22.2% vs. 11.6%±46.5%, P=0.02; γGT: −3.45%±17.8% vs. 4.62%±19.4%, P=0.045) (Table 2).”
What did not
“The percentage relative changes in fasting blood glucose and hemoglobin A1c were not significantly different between the two study groups (placebo vs. royal jelly: fasting blood glucose, −0.17%±7.9% vs. −0.08%±7.6%, P=0.95; hemoglobin A1c, −0.15%±2.0% vs. −0.09%±2.3%, P=0.91).”
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Healthy Japanese volunteers aged 20-60 years without diabetes, hypertension or dyslipidaemia, single centre (Kumamoto University); oral royal jelly tablet 690 mg/day (dried royal jelly, equivalent to 2040 mg fresh royal jelly) versus placebo tablet for 4 weeks
- Participants
- 88
- Comparator
- placebo
- Duration
- 28 days
- Endpoints measured
- 72